Striking the right balance between risk and innovation with Marek Wasiluk

Sylvain Berthelot welcomes Dr. Marek Wasiluk, CEO of ClinMark. With a career that spans from CRA to leading a global CRO, Marek brings a unique perspective on how clinical research organizations can embrace innovation while safeguarding trial quality.

Together, they explore the fine balance between adopting new technologies and managing operational risk. Marek shares how his background in medicine, quality assurance, and clinical operations shapes his approach to implementing digital solutions that not only meet regulatory expectations but also bring real value to sponsors and patients.

Sylvain and Marek discuss why CROs must be both cautious and bold when evaluating new tools, how to build trust with clients while innovating, and the importance of curiosity and adaptability in driving meaningful change.

Tune in to hear how CROs can move beyond “shiny new objects” and take a thoughtful, balanced approach to innovation in clinical trials.

Share via

See CRScube in action

Book a demo

Explore how our platform will elevate your team and clinical trial management.

Get insights straight to your inbox

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

See all resources

Featured resources

CRScube acquires Mednet to expand global eClinical capabilities

“Bringing CRScube and Mednet together is an important milestone in our journey to transform clinical trials" said Stanley Kim, CEO of CRScube.

The impact of geopolitics in clinical trial location with Scott Schliebner

Sylvain and Scott explore the growing uncertainty created by political change, regulatory shifts, and economic pressures, and how these factors are shaping sponsor strategies.

The people behind the data: Study team feedback on cubeCDMS

Measuring how well a product truly serves its users can be complex; the Net Promoter Score (NPS) offers a simple and powerful way to understand that relationship